- $966.85m
- $945.41m
- $545.91m
Brief: MoneyLion Reports Quarterly Total Revenues Of $94.9 Million
MoneyLion Inc expected to post a loss of 11 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Mersana Therapeutics, Tesla, Outlook Therapeutics
Brief: Moneylion Inc Sees Medium-Term Adjusted Revenue Cagr 35%-50%
Brief: MoneyLion Inc Says On Nov 23, 2022, Co Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From NYSE
MoneyLion Inc reports results for the quarter ended in September - Earnings Summary
MoneyLion Inc expected to post a loss of 12 cents a share - Earnings Preview
NYSE ORDER IMBALANCE 77976.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 355886.0 SHARES ON BUY SIDE
Brief: Zendrive Partners With MoneyLion
Brief: MoneyLion raises full year adjusted revenue guidance and reaffirms breakeven adjusted EBITDA target exiting 2022
Brief: MoneyLion Identifies Error In Certain Statements Related To Make-Whole Provision For MALKA Deal
NYSE ORDER IMBALANCE 58263.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 762118.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 103231.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 865702.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 280563.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 83825.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 59765.0 SHARES ON BUY SIDE